对严重疟疾病毒性蛋白质的广泛抑制抗体
Raphael A Reyes1, Sai Sundar Rajan Raghavan2,3, Nicholas K Hurlburt4
1Department of Microbiology, Immunology and Molecular Genetics, Long School of Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Nature
|November 20, 2024
概括
两种新的人类抗体在很大程度上抑制了Plasmodium falciparum红细胞膜蛋白1 (PfEMP1) 与EPCR结合,这是严重疟疾的关键因素. 这些发现为开发新型疟疾疫苗和治疗提供了洞察力.
科学领域:
- 免疫学
- 传染性疾病
- 结构生物学
背景情况:
- 严重的疟疾病原体包括 Plasmodium falciparum 感染的红细胞附着在微血管上.
- 红细胞膜蛋白1 (PfEMP1) 调节这种粘附,其中特定的变体与人体内皮蛋白C受体 (EPCR) 结合.
- 识别针对多种PfEMP1变体的抗体对于理解获得免疫力和开发干预措施至关重要.
研究的目的:
- 确定针对PfEMP1的CIDRα1域的广泛反应的人类单克隆抗体.
- 研究这些抗体对EPCR结合和寄生虫封存的抑制潜力.
- 阐明抗体广泛反应性和抑制机制的结构基础.
主要方法:
- 针对CIDRα1域的人类单克隆抗体的分离和表征.
- 在体外测试以评估复合和原生PfEMP1蛋白的EPCR结合抑制.
- 3D生物工程人类大脑微血管模型,以评估在流动下对寄生虫的抑制.
- 抗体-抗原复合物的结构分析 (晶体).
主要成果:
- 发现了两种针对CIDRα1域的广泛反应性人类单克隆抗体.
- 这些抗体有效地抑制了多种CIDRα1变异的EPCR结合,包括五个子类.
- 在3D脑微血管模型中证明了寄生虫封存的抑制.
- 结构研究显示了关键残留物在EPCR结合部位中的结合机制.
结论:
- 针对CIDRα1域上的保留表位的广泛反应性抗体代表了对严重疟疾获得免疫力的潜在常见机制.
- 这些抗体显示出针对严重疟疾的新型疫苗或疗法开发的巨大潜力.
- 了解广泛抗体识别的结构基础为合理的药物和疫苗设计提供了关键的见解.
相关概念视频
Humoral Immune Responses
66.4K
Overview
66.4K
Cross-reactivity
28.8K
Overview
28.8K
Myasthenia Gravis: Overview and Treatment
3.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.7K
Antibody Actions
3.9K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
3.9K
Inhibitors of Viral Protein Synthesis
73
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
73
Myasthenia Gravis ll: Pathophysiology
69
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
69


